Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: a multicenter parallel group study. The TRAFFIC Study Group.

[1]  P. Bernink,et al.  Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade. Results of the Felodipine ER and Metoprolol CR in Angina (FEMINA) Study. Working Group on Cardiovascular Research, The Netherlands (WCN). , 1997, European heart journal.

[2]  A. Keren,et al.  Comparison between metoprolol orally osmotic once daily and metoprolol two or three times daily in suppressing exercise-induced and daily myocardial ischemia. , 1996, The American journal of cardiology.

[3]  D. Ardissino,et al.  Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. , 1996, Journal of the American College of Cardiology.

[4]  P. Rønnevik,et al.  Felodipine in addition to beta-adrenergic blockade for angina pectoris. a multicentre, randomized, placebo-controlled trial. , 1995, European heart journal.

[5]  K. Schulte.  24 h anti-anginal and anti-ischaemic effects with once daily felodipine. A double-blind comparison with nifedipine, twice daily, and placebo in patients with stable exercise induced angina pectoris. , 1995, European heart journal.

[6]  D. V. van Veldhuisen,et al.  Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris. , 1994, The American journal of cardiology.

[7]  A. Tisell,et al.  Felodipine versus placebo in stable effort-induced angina pectoris in patients inadequately controlled with metoprolol--a dose-finding study. , 1994, Journal of cardiovascular pharmacology.

[8]  S. Glasser,et al.  Amlodipine combined with beta blockade for chronic angina: Results of a multicenter, placebo‐controlled, randomized double‐blind study , 1992, Clinical cardiology.

[9]  S. Savonitto,et al.  Twenty-four-hour activity of felodipine extended release in chronic stable angina pectoris. , 1991, The American journal of cardiology.

[10]  A. Rubboli,et al.  Felodipine in chronic stable angina: a randomized, double-blind, placebo-controlled, crossover study. , 1990, European heart journal.

[11]  K. Jennings,et al.  The effects of treatment with felodipine as a single agent in coronary artery disease. , 1989, British heart journal.

[12]  J. Staessen,et al.  Primary Prevention With Metoprolol in Patients With Hypertension , 1988 .

[13]  C. Pandullo,et al.  Acute effects of felodipine in exertional angina pectoris. , 1988, The American journal of cardiology.

[14]  J. Tuomilehto,et al.  Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. , 1988, JAMA.

[15]  M. B. Ccomerford,et al.  A clinical evaluation of sustained release metoprolol durules in the treatment of angina pectoris , 1982 .

[16]  O. Keyriläinen,et al.  Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris. , 1979, Annals of clinical research.

[17]  E. Sonnenblick,et al.  Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. , 1992, European heart journal.

[18]  P. Verdecchia,et al.  Increased exercise tolerance and reduced electrocardiographic ischaemia 3 and 12 hours after oral felodipine in effort angina. , 1989, European heart journal.

[19]  L. Orö.  Treatment of angina pectoris with metoprolol. A comparison between Durules administered once daily and tablets administered twice daily. , 1981, Annals of clinical research.